Food and Drug Administration officials aren't sure just how the two are linked. That's what they told the House subcommittee on Criminal Justice, Drug Policy and Human Resources, investigating the deaths of four women who died of an infection from Clostridium sordellii, a rare but deadly bacterium, after taking the abortion pill Mifeprex (mifepristone). Rep. Mark Souder (R-Ind.) convened the hearing to see if the drug demonstrated a "low standard for women's health," reported the Associated Press (5/17/06).
Food and Drug Administration officials aren't sure just how the two are linked. That's what they told the House subcommittee on Criminal Justice, Drug Policy and Human Resources, investigating the deaths of four women who died of an infection from Clostridium sordellii, a rare but deadly bacterium, after taking the abortion pill Mifeprex (mifepristone). Rep. Mark Souder (R-Ind.) convened the hearing to see if the drug demonstrated a "low standard for women's health," reported the Associated Press (5/17/06).
"It is not possible at this time to determine whether the current mifepristone/misoprostol regimen for abortion results in increased risk of C sordellii infection," said Dr. Janet Woodcock, the FDA's deputy commissioner for operations.
Theories abound, though. Some believe that the drug may suppress the immune system. Others say the infection may indicate an emerging obstetric threat. Opponents of the abortion pill, though, suspect a link and are pointing to the deaths to push for a ban of the drug.
Increase in ED visits for hypertensive disorders from 2006 to 2020 reported
September 18th 2024In a recent study, reported rates on emergency department utilization for hypertensive disorders of pregnancy and the postpartum period were higher in 2020 than 2006, with rates especially high among non-Hispanic Black, Hispanic, and Asian patients.
Read More
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More